| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3193254 | Annals of Allergy, Asthma & Immunology | 2007 | 6 Pages |
Abstract
The administration of MVIT at 6-month intervals does not provide suitable protection in BV-allergic patients, and they should continue MVIT at the accepted 1- to 3-month intervals.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Arnon MD, Ronit MD,